E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 10/16/2015 in the Prospect News PIPE Daily.

Medifirst Solutions completes $31,000 private placement of convertible

Medical technology developer sells promissory note due Oct. 8, 2016

By Devika Patel

Knoxville, Tenn., Oct. 16 – Medifirst Solutions Inc. sold a $31,000 convertible promissory note in a private placement on Oct. 12, according to an 8-K filed Friday with the Securities and Exchange Commission. The deal priced on Oct. 8.

The note is due on Oct. 8, 2016. The conversion price is 58% of the lowest trading price of the stock for the 20 days preceding conversion.

Proceeds will be used for general working capital purposes.

The Freehold, N.J., company develops a line of medical and health-care products and technologies, including a mobile laser unit to treat skin-related concerns and an LED light therapy system to treat pain.

Issuer:Medifirst Solutions Inc.
Issue:Convertible promissory note
Amount:$31,000
Maturity:Oct. 8, 2016
Conversion price:58% of the lowest trading price of the stock for the 20 days preceding conversion
Warrants:No
Pricing date:Oct. 8
Settlement date:Oct. 12
Stock symbol:OTCBB: MFST
Stock price:$0.01 at close Oct. 7
Market capitalization:$299,720

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.